Sophie Grabar

Institut National d'études démographiques

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (4)

Fabio Candotti

Full Professor of Medicine

Lausanne University Hospital

SWITZERLAND

View details

Dominique Costagliola

Sorbonne Université

FRANCE

View details

CHRISTINE KATLAMA

FRANCE

View details

Alain Makinson

University Hospital of Montpellier

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sophie Grabar

Research Interests

Explore related searches

Contact this professor

Articles (10)

Disseminated Histoplasmosis in Persons Living with HIV, France and Overseas Territories,1992-2021

Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4-FHDH)

Dépistage et diagnostic précoce des cancers chez les personnes vivant avec le VIH à l’ère des antirétroviraux : spécificités et enjeux

Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

Estimation of Improvements in Mortality in Spectrum among Adults with HIV Receiving Antiretroviral Therapy in High-Income Countries

HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic review

High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022

Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies

Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.

Collaborators (4)

Fabio Candotti

Dominique Costagliola

CHRISTINE KATLAMA

Alain Makinson

Make your next move.